CDCA5 C-terminal Antibody

About the Target

CDCA5 (cell division cycle associated 5), commonly referred to as sororin, is a crucial protein necessary for sister chromatid cohesion during the S and G2/M phases of the cell cycle, primarily through its interaction with the cohesin complex. The C-terminal region of CDCA5 plays a vital role by mediating binding to the cohesin subunit SA2 and undergoing post-translational modifications that affect the protein's stability and function. Depending on the literature source, CDCA5 may also be discussed as CDCA5 C-terminal.

Reported cellular context includes chromosome, cytoplasm, and nucleus, which can matter when signal is compared across treatments or changing cell states. Following CDCA5 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

CDCA5 is commonly interpreted in the context of cancer and cell cycle research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans chromosome, cytoplasm, and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between chromosome, cytoplasm, and nucleus across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• cell-cycle linked differences in abundance, timing, or compartmental enrichment
• co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CDCA5. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CDCA5 reflect biology rather than handling. When interpreting CDCA5, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep CDCA5 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.